Trial Profile
A phase I trial of RAP-101 for treatment of Progressive Multifocal Leukoencephalopathy (PML)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs DAPTA (Primary)
- Indications Progressive multifocal leukoencephalopathy
- Focus Adverse reactions
- 28 Apr 2016 New trial record